These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 37103313)

  • 1. The Use of Specialized Pro-Resolving Mediators in Biomaterial-Based Immunomodulation.
    Sousa AB; Barbosa JN
    J Funct Biomater; 2023 Apr; 14(4):. PubMed ID: 37103313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specialized pro-resolving mediator network: an update on production and actions.
    Chiang N; Serhan CN
    Essays Biochem; 2020 Sep; 64(3):443-462. PubMed ID: 32885825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PCOS: A Chronic Disease That Fails to Produce Adequately Specialized Pro-Resolving Lipid Mediators (SPMs).
    Regidor PA; de la Rosa X; Müller A; Mayr M; Gonzalez Santos F; Gracia Banzo R; Rizo JM
    Biomedicines; 2022 Feb; 10(2):. PubMed ID: 35203665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pro-Resolving Lipid Mediators (SPMs) and Their Actions in Regulating miRNA in Novel Resolution Circuits in Inflammation.
    Recchiuti A; Serhan CN
    Front Immunol; 2012; 3():298. PubMed ID: 23093949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of T-Cell Immune Responses by Pro-Resolving Lipid Mediators.
    Perez-Hernandez J; Chiurchiù V; Perruche S; You S
    Front Immunol; 2021; 12():768133. PubMed ID: 34868025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possibility of averting cytokine storm in SARS-COV 2 patients using specialized pro-resolving lipid mediators.
    Yasmeen N; Selvaraj H; Lakhawat SS; Datta M; Sharma PK; Jain A; Khanna R; Srinivasan J; Kumar V
    Biochem Pharmacol; 2023 Mar; 209():115437. PubMed ID: 36731803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specialized pro-resolving mediators in cardiovascular diseases.
    Fredman G; Spite M
    Mol Aspects Med; 2017 Dec; 58():65-71. PubMed ID: 28257820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose pro-resolving mediators temporally reset the resolution response to microbial inflammation.
    Serhan CN; Chiang N; Nshimiyimana R
    Mol Med; 2024 Sep; 30(1):153. PubMed ID: 39294573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specialized pro-resolving lipid mediators in endodontics: a narrative review.
    Aubeux D; Peters OA; Hosseinpour S; Tessier S; Geoffroy V; Pérez F; Gaudin A
    BMC Oral Health; 2021 May; 21(1):276. PubMed ID: 34030680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specialized Proresolving Mediators for Therapeutic Interventions Targeting Metabolic and Inflammatory Disorders.
    Han YH; Lee K; Saha A; Han J; Choi H; Noh M; Lee YH; Lee MO
    Biomol Ther (Seoul); 2021 Sep; 29(5):455-464. PubMed ID: 34162770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resolvins, Protectins, and Maresins: DHA-Derived Specialized Pro-Resolving Mediators, Biosynthetic Pathways, Synthetic Approaches, and Their Role in Inflammation.
    Ferreira I; Falcato F; Bandarra N; Rauter AP
    Molecules; 2022 Mar; 27(5):. PubMed ID: 35268778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SPMs exert anti-inflammatory and pro-resolving effects through positive allosteric modulation of the prostaglandin EP4 receptor.
    Alnouri MW; Roquid KA; Bonnavion R; Cho H; Heering J; Kwon J; Jäger Y; Wang S; Günther S; Wettschureck N; Geisslinger G; Gurke R; Müller CE; Proschak E; Offermanns S
    Proc Natl Acad Sci U S A; 2024 Oct; 121(41):e2407130121. PubMed ID: 39365815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles, Actions, and Therapeutic Potential of Specialized Pro-resolving Lipid Mediators for the Treatment of Inflammation in Cystic Fibrosis.
    Recchiuti A; Mattoscio D; Isopi E
    Front Pharmacol; 2019; 10():252. PubMed ID: 31001110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resolution of inflammation in oral diseases.
    Eltay EG; Van Dyke T
    Pharmacol Ther; 2023 Jul; 247():108453. PubMed ID: 37244405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Docosapentaenoic acid derived metabolites and mediators - The new world of lipid mediator medicine in a nutshell.
    Weylandt KH
    Eur J Pharmacol; 2016 Aug; 785():108-115. PubMed ID: 26546723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specialized pro-resolving mediators: biosynthesis and biological role in bacterial infections.
    Jordan PM; Werz O
    FEBS J; 2022 Jul; 289(14):4212-4227. PubMed ID: 34741578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New translational and experimental insights into the role of pro-resolving lipid mediators in inflammatory bowel disease.
    Pascoal LB; Palma BB; Chaim FHM; de Castro MM; Damázio TA; Franceschini APMF; Milanski M; Velloso LA; Leal RF
    World J Exp Med; 2022 Jan; 12(1):1-15. PubMed ID: 35096550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is Lipid Metabolism of Value in Cancer Research and Treatment? Part II: Role of Specialized Pro-Resolving Mediators in Inflammation, Infections, and Cancer.
    Babar MU; Nassar AF; Nie X; Zhang T; He J; Yeung J; Norris P; Ogura H; Muldoon A; Chen L; Libreros S
    Metabolites; 2024 May; 14(6):. PubMed ID: 38921449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Specialized Pro-Resolving Mediators in Neuropathic Pain.
    Leuti A; Fava M; Pellegrini N; Maccarrone M
    Front Pharmacol; 2021; 12():717993. PubMed ID: 34456731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resolution of inflammation: An organizing principle in biology and medicine.
    Panigrahy D; Gilligan MM; Serhan CN; Kashfi K
    Pharmacol Ther; 2021 Nov; 227():107879. PubMed ID: 33915177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.